|
Q2 2025
|
4 |
268,465 |
MRNA, SANA, FHTX, Seres Therapeutics Inc
|
13F-HR
|
8/14/2025 |
000095012325008304 |
|
Q1 2025
|
4 |
235,769 |
MRNA, FHTX, SANA, MCRB
|
13F-HR
|
5/15/2025 |
000095012325005707 |
|
Q4 2024
|
5 |
334,222 |
MRNA, FHTX, SANA, OMGA
|
13F-HR
|
2/14/2025 |
000095012325002708 |
|
Q3 2024
|
6 |
591,878 |
MRNA, FHTX, SANA, OMGA
|
13F-HR
|
11/14/2024 |
000095012324011756 |
|
Q2 2024
|
6 |
843,359 |
MRNA, SANA, FHTX, OMGA
|
13F-HR
|
8/14/2024 |
000095012324008727 |
|
Q1 2024
|
7 |
1,524,565 |
MRNA, SANA, OMGA, FHTX
|
13F-HR
|
5/15/2024 |
000095012324005589 |
|
Q4 2023
|
7 |
1,325,311 |
MRNA, SANA, OMGA, FHTX
|
13F-HR
|
2/14/2024 |
000095012324002510 |
|
Q3 2023
|
9 |
1,377,673 |
MRNA, SANA, FHTX, OMGA
|
13F-HR
|
11/14/2023 |
000095012323010821 |
|
Q2 2023
|
10 |
2,240,750 |
MRNA, SANA, OMGA, MCRB
|
13F-HR
|
8/14/2023 |
000095012323008070 |
|
Q1 2023
|
11 |
2,573,424 |
MRNA, OMGA, MCRB, SANA
|
13F-HR
|
5/15/2023 |
000095012323005258 |
|
Q4 2022
|
12 |
3,132,284 |
MRNA, OMGA, SANA, MCRB
|
13F-HR
|
2/14/2023 |
000095012323002460 |
|
Q3 2022
|
12 |
2,375,805 |
MRNA, SANA, MCRB, OMGA
|
13F-HR
|
11/14/2022 |
000095012322012261 |
|
Q2 2022
|
12 |
2,654,624 |
MRNA, SANA, FHTX, EVLO
|
13F-HR
|
8/15/2022 |
000095012322009421 |
|
Q1 2022
|
13 |
4,258,761 |
MRNA, SANA, RUBY, FHTX
|
13F-HR
|
5/16/2022 |
000095012322006309 |
|
Q4 2021
|
13 |
6,467,997 |
MRNA, SANA, RUBY, OMGA
|
13F-HR
|
2/14/2022 |
000095012322002901 |
|
Q3 2021
|
13 |
9,549,130 |
MRNA, SANA, RUBY, OMGA
|
13F-HR
|
11/15/2021 |
000095012321015487 |
|
Q2 2021
|
12 |
7,829,539 |
MRNA, RUBY, SANA, MCRB
|
13F-HR
|
8/16/2021 |
000095012321011113 |
|
Q1 2021
|
12 |
6,244,355 |
MRNA, SANA, RUBY, MCRB
|
13F-HR
|
5/17/2021 |
000095012321007079 |
|
Q4 2020
|
11 |
5,493,282 |
MRNA, SGTX, MCRB, RUBY
|
13F-HR
|
2/16/2021 |
000095012321002948 |
|
Q3 2020
|
8 |
3,619,952 |
MRNA, MCRB, KLDO, DNLI
|
13F-HR
|
11/16/2020 |
000095012320012128 |
|
Q2 2020
|
8 |
3,441,586 |
MRNA, RUBY, DNLI, KLDO
|
13F-HR
|
8/13/2020 |
000095012320008652 |
|
Q1 2020
|
8 |
2,133,438 |
MRNA, RUBY, DNLI, KLDO
|
13F-HR
|
5/14/2020 |
000095012320004927 |
|
Q4 2019
|
9 |
1,788,867 |
MRNA, RUBY, DNLI, KLDO
|
13F-HR
|
2/13/2020 |
000095012320001884 |
|
Q3 2019
|
10 |
1,828,054 |
MRNA, RUBY, KLDO, DNLI
|
13F-HR
|
11/14/2019 |
000095012319011393 |
|
Q2 2019
|
10 |
2,310,279 |
MRNA, RUBY, KLDO, DNLI
|
13F-HR
|
8/13/2019 |
000095012319007818 |
|
Q1 2019
|
8 |
2,642,256 |
MRNA, RUBY, KLDO, DNLI
|
13F-HR
|
5/14/2019 |
000101297519000346 |
|
Q4 2018
|
7 |
2,047,628 |
MRNA, RUBY, EVLO, DNLI
|
13F-HR
|
2/13/2019 |
000101297519000145 |
|
Q3 2018
|
6 |
1,513,015 |
RUBY, EVLO, DNLI, MCRB
|
13F-HR
|
11/13/2018 |
000101297518001201 |
|
Q2 2018
|
5 |
522,113 |
EVLO, DNLI, MCRB, SYRS
|
13F-HR
|
8/7/2018 |
000101297518000952 |
|
Q1 2018
|
4 |
344,896 |
DNLI, MCRB, SYRS, QTRX
|
13F-HR
|
5/15/2018 |
000101297518000415 |
|
Q4 2017
|
5 |
394,322 |
DNLI, MCRB, EDIT, QTRX
|
13F-HR
|
2/14/2018 |
000101297518000160 |
|
Q3 2017
|
4 |
298,998 |
MCRB, SYRS, EDIT, T2 BIOSYSTEMS INC
|
13F-HR
|
11/3/2017 |
000101297517000806 |
|
Q2 2017
|
4 |
283,568 |
MCRB, SYRS, EDIT, T2 BIOSYSTEMS INC
|
13F-HR
|
8/2/2017 |
000101297517000578 |
|
Q1 2017
|
7 |
376,254 |
MCRB, SYRS, EDIT, AGIO
|
13F-HR
|
5/10/2017 |
000101297517000377 |
|
Q4 2016
|
7 |
307,344 |
MCRB, SYRS, EDIT, AGIO
|
13F-HR
|
2/13/2017 |
000101297517000113 |
|
Q3 2016
|
7 |
365,999 |
MCRB, SYRS, AGIO, EDIT
|
13F-HR
|
11/14/2016 |
000101297516001561 |